Sava Infond’s Novo Nordisk NVO Stock Holding History

Sava Infond’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$786K	Hold	20,725	–	–	0.05%	123
2026 Q2	$994K	Hold	20,725	–	–	0.07%	107
2026 Q1	$762K	Hold	20,725	–	–	0.11%	114
2025 Q4	$1.05M	Sell	20,725 -2,000	-9%	-$102K	0.14%	96
2025 Q3	$1.26M	Buy	22,725 +3,125	+16%	+$183K	0.18%	84
2025 Q2	$1.35M	Sell	19,600 -1,100	-5%	-$74.8K	0.21%	80
2025 Q1	$1.44M	Buy	20,700 +2,200	+12%	+$182K	0.27%	78
2024 Q4	$1.59M	Buy	+18,500	New	+$2M	0.28%	69

Other funds holding NVO

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return

Markel Group Glen Allen, Virginia $12.8B AUM 8.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.11B AUM 22.59% 1-Year Est. Return

Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return

Sava Infond's NVO Position: Q3 2026 in Review

Sava Infond held its Novo Nordisk (NVO) position steady in Q3 2026 at 20,725 shares worth $786K. The position accounts for 0.05% of the portfolio, ranked #123.

Sava Infond first reported a position in NVO in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.59M in Q4 2024. 617 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Sava Infond held 20,725 shares of Novo Nordisk worth $786K as of Q3 2026.
Sava Infond left its Novo Nordisk share count unchanged in Q3 2026.
Novo Nordisk made up 0.05% of Sava Infond's portfolio in Q3 2026, its #123 holding.
Sava Infond first reported a position in Novo Nordisk in Q4 2024 and has held it in 8 quarters since.
Sava Infond's Novo Nordisk position peaked at $1.59M in Q4 2024.
617 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Sava Infond's 13F filing for Q3 2026, filed 28 Oct 2026.